期刊论文详细信息
Frontiers in Medicine | |
Corrigendum: Optimized riboswitch-regulated AAV vector for VEGF-B gene therapy | |
Medicine | |
Seppo Ylä-Herttuala1  Sanna K. Peltola2  Igor Oruetxebarria2  Saana Lepola2  Hanna M. Leinonen2  Tiina Nieminen2  Kari J. Airenne2  Eevi M. Lipponen2  Lionel Galibert2  Petra Tikkanen2  Hanna P. Lesch2  Anniina J. Valkama2  Reetta A. E. Eriksson3  Piia Käyhty3  | |
[1] A.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, Kuopio, Finland;Gene Therapy Unit and Research Center, Kuopio University Hospital, Kuopio, Finland;Kuopio Center for Gene and Cell Therapy, Kuopio, Finland;Kuopio Center for Gene and Cell Therapy, Kuopio, Finland;A.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, Kuopio, Finland; | |
关键词: riboswitch; ON-switch; gene therapy; AAV (adeno-associated virus); VEGF-B; tetracycline; transgene expression regulation; | |
DOI : 10.3389/fmed.2023.1143748 | |
received in 2023-01-13, accepted in 2023-02-13, 发布年份 2023 | |
来源: Frontiers | |
【 摘 要 】
【 授权许可】
Unknown
Copyright © 2023 Eriksson, Nieminen, Galibert, Peltola, Tikkanen, Käyhty, Leinonen, Oruetxebarria, Lepola, Valkama, Lipponen, Lesch, Ylä-Herttuala and Airenne.
【 预 览 】
Files | Size | Format | View |
---|---|---|---|
RO202310107105202ZK.pdf | 69KB | download |